149
Views
0
CrossRef citations to date
0
Altmetric
Review

Implantable loop recorders in patients with atrial fibrillation

ORCID Icon, , & ORCID Icon
Pages 919-928 | Received 11 Oct 2022, Accepted 28 Nov 2022, Published online: 09 Dec 2022

References

  • Kornej J, Börschel CS, Benjamin EJ, et al., Epidemiology of atrial fibrillation in the 21st century, novel methods and new insights. Circ Res. 2020;127(1):4–20.
  • Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation. Circulation. 2014 cited 2022 Sep 7;129(8):837–847.
  • Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation Internet]. 2006 [cited 2022 Sep 7;114:e257–354. Available from https://www.ahajournals.org/doi/10.1161/circulationaha.106.177292
  • Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation, epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017 cited 2022 Sep 7;120(9):1501–1517.
  • Healey JS, Alings M, Ha A, et al. Subclinical atrial fibrillation in older patients. Circulation. 2017 cited 2022 Sep 11;136(14):1276–1283.
  • Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11(11):639–654.
  • Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J Internet]. 2016 cited 2022 Sep 5;37:2893–2962. Available from https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehw210
  • Mogensen UM, Jhund PS, Abraham WT, et al. Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70(20):2490–2500.
  • Chung MK, Refaat M, Shen W-K, et al. Atrial Fibrillation. J Am Coll Cardiol. 2020 cited 2022 Sep 5;75(14):1689–1713.
  • Steinberg JS, Varma N, Cygankiewicz I, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Ann Noninvasive Electrocardiol. 2017;22(3):e12447.
  • Sharma AN, Baranchuk A. Ambulatory external electrocardiography monitoring, holter, extended holter, mobile cardiac telemetry monitoring. Card Electrophysiol Clin. 2021;13(3):427–438.
  • Godin R, Yeung C, Baranchuk A, et al. Screening for atrial fibrillation using a mobile, single-lead electrocardiogram in Canadian primary care clinics. Can J Cardiol. 2019 cited 2020 Oct 20;35(7):840–845.
  • Halcox JPJ, Wareham K, Cardew A, et al. Assessment of remote heart rhythm sampling using the alivecor heart monitor to screen for atrial fibrillation, the REHEARSE-AF study. Circulation. 2017;136(19):1784–1794.
  • Wegner FK, Kochhäuser S, Ellermann C, et al. Prospective blinded evaluation of the smartphone-based alivecor kardia ECG monitor for atrial fibrillation detection, The PEAK-AF study. Eur J Intern Med. 2020;73:72–75.
  • Ding EY, Marcus GM, McManus DD. Emerging Technologies for Identifying Atrial Fibrillation. Circ Res. Internet]. 2020 cited 2022 Nov 18;127(1)::128–142.
  • Varma N, Cygankiewicz I, Turakhia MP, et al. 2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mhealth in arrhythmia management, digital medical tools for heart rhythm professionals. Cardiovasc Digit Health J [Internet]. 2021 cited 2022 Sep 7;2:4–54. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890358/
  • Wasserlauf J, You C, Patel R, et al. Smartwatch performance for the detection and quantification of atrial fibrillation. Circ Arrhythm Electrophysiol. 2019;12(6):e006834.
  • Lohrmann G, Passman R. The future of long-term monitoring following catheter and surgical intervention for atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32(10):2808–2812.
  • BIOTRONIK [Internet]. [cited 2022 Sep 17]. Available from, https://www.biotronik.com/en-us.
  • Medtronic. Home [Internet]. [cited 2022 Sep 17]. Available from, https://www.medtronic.com/ca-en/index.html.
  • Advancing science for life - US - Boston scientific. [cited 2022 Sep 17]. Available from, https://www.bostonscientific.com/en-US/Home.html.
  • Confirm RxTM Insertable Cardiac Monitor (ICM) | Abbott Confirm RxTM. Internet]. ICM. [cited 2022 Sep 17]. Available from: https://confirmyourrhythm.com/
  • Diederichsen SZ, Haugan KJ, Kronborg C, et al. Comprehensive evaluation of rhythm monitoring strategies in screening for atrial fibrillation. Circulation. 2020 cited 2022 Sep 12;141(19):1510–1522.
  • Cotter PE, Martin PJ, Ring L, et al. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology. 2013;80(17):1546–1550.
  • Sanna T, Diener H-C, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486.
  • Rojo-Martinez E, Sandín-Fuentes M, Calleja-Sanz AI, et al. High performance of an implantable Holter monitor in the detection of concealed paroxysmal atrial fibrillation in patients with cryptogenic stroke and a suspected embolic mechanism. Rev Neurol. 2013;57(6):251–257.
  • Seow S-C, How A-K, Chan S-P, et al. High incidence of occult atrial fibrillation in asian patients with cryptogenic stroke. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2018;27(8):2182–2186.
  • Etgen T, Hochreiter M, Mundel M, et al. Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke, an audit report. Stroke. 2013;44(7):2007–2009.
  • Ritter MA, Kochhäuser S, Duning T, et al. Occult atrial fibrillation in cryptogenic stroke, detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke. 2013;44(5):1449–1452.
  • Poli S, Diedler J, Härtig F, et al. Insertable cardiac monitors after cryptogenic stroke – a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol. 2016 cited 2022 Nov 21;23(2):375–381.
  • Marks D, Ho R, Then R, et al. Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke, The value of p wave dispersion in predicting arrhythmia occurrence. Int J Cardiol. 2021;327:86–92.
  • Milstein NS, Musat DL, Allred J, et al. Detection of atrial fibrillation using an implantable loop recorder following cryptogenic stroke, implications for post-stroke electrocardiographic monitoring. J Interv Card Electrophysiol Int J Arrhythm Pacing. 2020;57(1):141–147.
  • Pecha S, Wilke I, Yildirim Y, et al. Implantable loop recorder monitoring in patients with cryptogenic stroke - Detection and treatment of different clinically relevant arrhythmias. J Electrocardiol. 2020;60:102–106.
  • Christensen LM, Krieger DW, Højberg S, et al. Paroxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke. Final results from the surprise study. Eur J Neurol. 2014;21(6):884–889.
  • Bettin M, Dechering D, Kochhäuser S, et al. Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke, time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial). Clin Res Cardiol Off J Ger Card Soc. 2019;108(3):309–314.
  • Noubiap JJ, Thomas G, Middeldorp ME, et al. Atrial fibrillation detection using insertable cardiac monitor after stroke, A real-world cohort study .J Cardiovasc Electrophysiol .Internet]. [cited 2022 Nov 21];n/a. Available https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15744
  • Desai AD, Howe E, Coromilas E, et al. Predictors of atrial fibrillation on implantable cardiac monitoring for cryptogenic stroke. J Interv Card Electrophysiol Int J Arrhythm Pacing. 2022;65(1):7–14.
  • Israel C, Kitsiou A, Kalyani M, et al. Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders. Thromb Haemost. 2017;117(10):1962–1969.
  • Pikija S, Rösler C, Leitner U, et al. Neurologist-led management of implantable loop-recorders after embolic stroke of undetermined source. Front Neurol. 2021;12:816511.
  • Víctor CU, Carolina PE, Jorge TR, et al. Incidence and predictive factors of hidden atrial fibrillation detected by implantable loop recorder after an embolic stroke of undetermined source. J Atr Fibrillation. 2018;11(3):2078.
  • Kitsiou A, Rogalewski A, Kalyani M, et al. Atrial fibrillation in patients with embolic stroke of undetermined source during 3 years of prolonged monitoring with an implantable loop recorder. Thromb Haemost. 2021;121(6):826–833.
  • Buck BH, Hill MD, Quinn FR, et al. Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke, the PER DIEM randomized clinical trial. JAMA. [Internet]. 2021 cited 2022 Sep 12;325(21):2160–2168. Available from].
  • Bernstein RA, Kamel H, Granger CB, et al. Effect of long-term continuous cardiac monitoring vs usual care on detection of atrial fibrillation in patients with stroke attributed to large- or small-vessel disease, the STROKE-AF randomized clinical trial. JAMA. 2021 cited 2022 Sep 12;325(6):2169–2177.
  • Aggarwal G, Aggarwal S, Alla V, et al. Subcutaneous cardiac rhythm monitors, a comprehensive review. J Atr Fibrillation. 2021;13(5):2387.
  • Van Gelder IC, Healey JS, Hjgm C, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38:1339–1344.
  • Kaplan RM, Koehler J, Ziegler PD, et al. Stroke risk as a function of atrial fibrillation duration and CHA 2 DS 2 -VASc score. Circulation. 2019 cited 2022 Nov 18;140(20):1639–1646.
  • Glotzer TV, Hellkamp AS, Zimmerman J, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation. 2003 cited 2022 Nov 18;107(12):1614–1619.
  • Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk, the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2(5):474–480.
  • Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 cited 2022 Nov 18;366(2):120–129.
  • Capucci A, Santini M, Padeletti L, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46(10):1913–1920.
  • Perino AC, Fan J, Askari M, et al. Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation. Circulation. 2019;139(22):2502–2512.
  • Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart rhythm society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol Internet]. 2020 [cited 2022 Nov 18];36:1847–1948. Available from https://www.onlinecjc.ca/article/S0828-282X(20)30991-0/fulltext
  • Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), The task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498. Internet]. cited 2022 Nov 18
  • January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation, A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation Internet]. 2019 cited 2022 Sep 12;140:e125–151. Available from https://www.ahajournals.org/doi/10.1161/CIR.0000000000000665
  • Ruwald MH, Hansen ML, Lamberts M, et al. Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age. Am J Cardiol. 2013;112(10):1610–1615.
  • Jansen S, Frewen J, Finucane C, et al. AF is associated with self-reported syncope and falls in a general population cohort. Age Ageing. 2015;44(4):598–603.
  • Malik V, Gallagher C, Linz D, et al. Atrial fibrillation is associated with syncope and falls in older adults, a systematic review and meta-analysis. Mayo Clin Proc. 2020 cited 2022 Sep 11;95(4):676–687.
  • McIntyre WF, Liebrecht K, Daba L, et al. Diagnostic value of implantable loop recorders in elderly adults. J Am Geriatr Soc. 2016 cited 2022 Sep 11;64(6):1370–1372.
  • Ibrahim OA, Drew D, Hayes CJ, et al. Implantable loop recorders in the real world, a study of two Canadian centers. J Interv Card Electrophysiol. 2017 cited 2022 Sep 5;50(2):179–185.
  • Arcinas LA, McIntyre WF, Hayes CJ, et al. Atrial fibrillation in elderly patients with implantable loop recorders for unexplained syncope. Ann Noninvasive Electrocardiol. 2019 cited 2020 Oct 20;24(3):e12630.
  • Shen W-K, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope, a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation Internet]. 2017 cited 2022 Sep 11;136:e60–122. Available from https://www.ahajournals.org/doi/10.1161/CIR.0000000000000499
  • Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–1948. Internet]. cited 2022 Sep 11
  • Philippsen TJ, Christensen LS, Hansen MG, et al. Detection of subclinical atrial fibrillation in high-risk patients using an insertable cardiac monitor. JACC Clin Electrophysiol. 2017 cited 2022 Sep 11;3(13):1557–1564.
  • Nasir JM, Pomeroy W, Marler A, et al. Predicting determinants of atrial fibrillation or flutter for therapy elucidation in patients at risk for thromboembolic events (PREDATE AF) study. Heart Rhythm. 2017 cited 2022 Sep 11;14(7):955–961.
  • Yeung C, Drew D, Hammond S, et al. Extended cardiac monitoring in patients with severe sleep apnea and no history of atrial fibrillation (The Reveal XT-SA Study). Am J Cardiol. 2018 cited 2022 Sep 11;122(11):1885–1889.
  • Reiffel JA, Verma A, Kowey PR, et al. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population, the REVEAL AF study. JAMA Cardiol. 2017 cited 2022 Sep 11;2(10):1120–1127.
  • Svendsen JH, Diederichsen SZ, Højberg S, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021 cited 2022 Sep 11;398(10310):1507–1516.
  • Chen LY, Chung MK, Allen LA, et al. Atrial fibrillation burden, moving beyond atrial fibrillation as a binary entity, A scientific statement from the American Heart Association. Circulation. 2018 cited 2022 Sep 11;137(20):e623–44.
  • Davidson KW, Barry MJ, Mangione CM; US Preventive Services Task Force. Screening for atrial fibrillation, us preventive services task force recommendation statement. JAMA. 2022;327(4):360–367
  • Ntaios G. Embolic stroke of undetermined source, JACC review topic of the week. J Am Coll Cardiol. Internet]. 2020 cited 2022 Oct 6;75(3):333–340.
  • McMahon NE, Bangee M, Benedetto V, et al. Etiologic workup in cases of cryptogenic stroke. Stroke. 2020 cited 2022 Sep 12;51(5):1419–1427.
  • Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23):2191–2201.
  • Diener H-C, Sacco RL, Easton JD, et al. *Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019 cited 2022 Oct 6;380(20):1906–1917.
  • Liao J, Khalid Z, Scallan C, et al. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke, a systematic review. Stroke. 2007;38(11):2935–2940.
  • Seet RCS, Friedman PA, Rabinstein AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation. 2011;124(4):477–486.
  • Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467–2477.
  • Samaan S, Kohli U, Nazeer B, et al. Detection of atrial fibrillation by implantable loop recorders following cryptogenic stroke, A retrospective study of predictive factors and outcomes. J Electrocardiol. 2022;71:54–58.
  • Albers GW, Bernstein RA, Brachmann J, et al. Heart rhythm monitoring strategies for cryptogenic stroke, 2015 diagnostics and monitoring stroke focus group report. J Am Heart Assoc. 2016;5:e002944.
  • Sanghvi MM, Jones DM, Kalindjian J, et al. The utility of implantable loop recorders (ILR) in patient management, an age and indication stratified study in the outpatient-implant era. Eur Heart J Qual Care Clin Outcomes. 2022;(8)7:770–777.
  • Carrazco C, Golyan D, Kahen M, et al. Prevalence and risk factors for paroxysmal atrial fibrillation and flutter detection after cryptogenic ischemic stroke. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2018;27(1):203–209.
  • Ko D, Dai Q, Flynn DB, et al. Meta-analysis of randomized clinical trials comparing the impact of implantable loop recorder versus usual care after ischemic stroke for detection of atrial fibrillation and stroke risk. Am J Cardiol. 2022;162:100–104.
  • Huang W-Y, Ovbiagele B, Hsieh C-Y, et al. Association between implantable loop recorder use and secondary stroke prevention, a meta-analysis. Open Heart. 2022 cited 2022 Sep 12;9(1):e002034.
  • Dilaveris PE, Antoniou CK, Caiani EG, et al. ESC Working Group on e-Cardiology Position Paper, accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients, In collaboration with the council on stroke, the European heart rhythm association, and the digital health committee. Eur Heart J - Digit Health. 2022 cited 2022 Nov 18;3:341–358.
  • Rubiera M, Aires A, Antonenko K, et al. European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin. 2022 [Internet]. [cited 2022 Nov 18]. Available from, https://journals.sagepub.com/doi/full/10.1177/23969873221099478.
  • Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring, crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol. 2009;20(3):241–248.
  • Mahajan R, Perera T, Elliott AD, et al., Subclinical device-detected atrial fibrillation and stroke risk, a systematic review and meta-analysis. Eur Heart J. 2018;39(16):1407–1415.
  • Tiver KD, Quah J, Lahiri A, et al. Atrial fibrillation burden, an update-the need for a CHA2DS2-VASc-AFBurden score. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2021;23:665–673.
  • Go AS, Reynolds K, Yang J, et al. Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation, The KP-RHYTHM study. JAMA Cardiol. 2018;3(7):601–608.
  • Passman R, Leong-Sit P, Andrei A-C, et al. Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor, the rhythm evaluation for anticoagulation with continuous monitoring (REACT.COM) pilot study. J Cardiovasc Electrophysiol. 2016 cited 2022 Sep 13;27(3):264–270.
  • Martin DT, Bersohn MM, Waldo AL, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36(26):1660–1668.
  • Jansson V, Bergfeldt L, Schwieler J, et al. Atrial fibrillation burden, episode duration and frequency in relation to quality of life in patients with implantable cardiac monitor. Int J Cardiol Heart Vasc. 2021;34:100791.
  • Arya A, Piorkowski C, Sommer P, et al. Clinical implications of various follow up strategies after catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol PACE. 2007;30(4):458–462.
  • Verma A, Champagne J, Sapp J, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF), A prospective, multicenter study. JAMA Intern Med. 2013 cited 2022 Sep 5;173(2):149.
  • Davtyan K, Shatakhtsyan V, Poghosyan H, et al. Radiofrequency versus cryoballoon ablation of atrial fibrillation, an evaluation using ECG, holter monitoring, and implantable loop recorders to monitor absolute and clinical effectiveness. BioMed Res Int. 2018 cited 2022 Sep 14;2018:3629384.
  • Yang P, Pu L, Yang L, et al. Value of implantable loop recorders in monitoring efficacy of radiofrequency catheter ablation in atrial fibrillation. Med Sci Monit Int Med J Exp Clin Res. 2016;22:2846–2851.
  • Andrade JG, Champagne J, Dubuc M, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring. Circulation. 2019 cited 2022 Oct 6;140(22):1779–1788.
  • Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021 cited 2022 Oct 6;384(4):305–315.
  • Pecha S, Schäfer T, Hartel F, et al. Concomitant surgical atrial fibrillation ablation and event recorder implantation, better monitoring, better outcome? Interact Cardiovasc Thorac Surg. Internet]. 2013 cited 2022 Sep 14;16:465–469. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598051/
  • Palmisano P, Del Greco M, Mantica M, et al. Expert opinion on continuous rhythm monitoring of patients with atrial fibrillation for candidates or patients who have already undergone ablation. Int J Cardiol. 2020;305:76–81.
  • Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm Internet]. 2017 cited 2022 Oct 7;14:e275–e444. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019327/
  • Afzal MR, Mease J, Koppert T, et al. Incidence of false-positive transmissions during remote rhythm monitoring with implantable loop recorders. Heart Rhythm. 2020;17(1):75–80.
  • Mittal S, Oliveros S, Li J, et al. AI filter improves positive predictive value of atrial fibrillation detection by an implantable loop recorder. JACC Clin Electrophysiol. 2021;7(8):965–975.
  • Damiano RJ, Lawrance CP, Saint LL, et al. Detection of atrial fibrillation after surgical ablation: conventional versus continuous monitoring. Ann Thorac Surg. 2016;101(1):42–47.
  • Maj R, De Ceglia S, Piazzi E, et al. Cryoballoon ablation for paroxysmal atrial fibrillation, mid-term outcome evaluated by ECG monitoring with an implantable loop recorder. J Cardiovasc Electrophysiol. 2021;32(4):933–940.
  • Kusiak A, Jastrzębski M, Bednarski A, et al. Diagnostic value of implantable loop recorder in patients undergoing cryoballoon ablation of atrial fibrillation. Ann Noninvasive Electrocardiol Internet]. 2019 cited 2022 Oct 6;25:e12733. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358840/
  • Lee R, Mittal S. Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder. Heart Rhythm. 2018;15(2):287–295.
  • Little CJ, Foley PWX, Haynes D. 12Appropriate ILR programming improves detection of events and reduces inappropriate alerts. Reduction in home monitoring workload for physiologists made possible. EP Eur Internet]. 2018 cited 2022 Nov 19;20:iv6–iv7.
  • Nadkarni A, Devgun J, Jamal SM, et al. Subcutaneous cardiac rhythm monitors, state of the art review. Expert Rev Med Devices. 2021 cited 2022 Nov 19;18(7):587–596.
  • Davish S, Baker C, Fulks M, et al. Drowning in data, workflow changes improve the collection of clinically relevant and actionable data. Perspect Health Inf Manag Internet]. 2019 cited 2022 Nov 19;16:1d. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931045/
  • Bisignani A, De Bonis S, Mancuso L, et al. Implantable loop recorder in clinical practice. J Arrhythmia. 2018 cited 2022 Nov 19;35(1):25–32.
  • Solbiati M, Costantino G, Casazza G, et al. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. Cochrane Database Syst Rev Internet]. 2016 [cited 2022 Sep 11];2016:CD011637. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782592/
  • Umeojiako W, Hosamuddin H, Kabunga P. Peri-procedural antibiotics during loop recorder implantation, a real-world observational study. J Am Coll Cardiol. Internet]. 2020 cited 2022 Sep 17;75(11):358.
  • Ibrahim O, Drew D, Baranchuk A. Indications, complications, and diagnostic yield of implantable loop recorder monitoring. Can J Cardiol. Internet]. 2016 cited 2022 Sep 17;32(10):S287.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.